BridgeMD
New treatment option for Hearing Impairment
Official title Clinical Evaluation of Frequency Allocation for Bimodal CI Users
ClinicalTrials.gov ID: NCT06663917
What this study is testing
- What it's testing
- This study will examine experienced, bimodal cochlear implant (CI) patients who receive an alternative frequency allocation table (FAT) to determine how it improves sound quality, device satisfaction, and speech perception abilities with respect to the standard default FAT. The goal of this study is to investigate how improving place-pitch mismatch in bimodal CI users affects 1) sound quality, 2) satisfaction, and 3) speech perception.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 or older
- Regular usage of a cochlear implant device with at least 18 active electrodes, and compliance with programming/appointments
- Received a cochlear implant at least 6 months ago and use a hearing aid in the contralateral ear
- Pure tone average (.5, 1, and 2kHz) between 30 and 70 dB (decibel) hearing level in the contralateral (hearing aid) ear
- Standard FAT use for all programs prior to study participation
You likely can't join if
- Under age 18
- Non-English speaking. Participants that are Non-English speaking are excluded from this study due to the use of speech testing materials that are...
- Cognitively impaired
- Non-consistent device usage
- Greater than 70 dB hearing level pure tone average in the contralateral ear
- Normal hearing or mild hearing loss in the contralateral ear
See the full eligibility criteria
- Age 18 or older
- Regular usage of a cochlear implant device with at least 18 active electrodes, and compliance with programming/appointments
- Received a cochlear implant at least 6 months ago and use a hearing aid in the contralateral ear
- Pure tone average (.5, 1, and 2kHz) between 30 and 70 dB (decibel) hearing level in the contralateral (hearing aid) ear
- Standard FAT use for all programs prior to study participation
- No known anatomical abnormalities in either ear
- English speaking
- No known cognitive impairments
- At least 25% of people should use the Cochlear EA32 electrode
- Under age 18
- Non-English speaking. Participants that are Non-English speaking are excluded from this study due to the use of speech testing materials that are validated in the English language. Additionally, study team members are...
- Cognitively impaired
- Non-consistent device usage
- Greater than 70 dB hearing level pure tone average in the contralateral ear
- Normal hearing or mild hearing loss in the contralateral ear
- Non-standard FAT programs
- Use of any frequency transposition programming in hearing aid.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.